These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: A financial evaluation of the Becton Dickinson 360 infuser system.
    Author: Fiorenzo VJ, Kelly WN.
    Journal: Hosp Pharm; 1987 Jun; 22(6):563-6. PubMed ID: 10312122.
    Abstract:
    The cost effectiveness of a new syringe infuser system for intermittent delivery of drugs was compared to current methods (69% minibags, 30% frozen commercially available minibags, and 1% premixed minibags) of delivery. All costs including labor, equipment, raw drug, labeling, supplies, and wasted drug were compared. Personnel costs were calculated using time and motion studies performed by a third party. There were minimal problems associated with using the new infuser system, all of which were corrected as the system was implemented. Eighty-two percent (82%) of intermittent drugs (remaining was 17.4% minibags; 0.6% pre-mix) could be converted to this system. Initially, more time was associated with preparing syringes versus minibags, but after a short learning curve, time differences were insignificant. The time to prepare commercially available pre-mixed i.v.'s and frozen minibags (retrieve and label) was 1.02 minutes compared to 1.61 minutes to prepare a traditional minibag and 1.62 minutes to prepare a syringe. There was a $0.98 savings/dose preparing 82% of our intermittent doses in syringes versus our current system. This extrapolated to an annual savings after the first year of $74,230, which was 28.0% of our i.v. admixture system costs. The BD 360 Infuser System is a significant cost savings device for intermittent drug delivery.
    [Abstract] [Full Text] [Related] [New Search]